The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study

This publication has 10 references indexed in Scilit:

• Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes
  The Lancet, 1995
• Paraoxonase: another factor in NIDDM cardiovascular disease
  The Lancet, 1995
• A Polymorphism of the Paraoxonase Gene Associated With Variation in Plasma Lipoproteins in a Genetic Isolate
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
  Atherosclerosis, 1993
• The molecular basis of the human serum paraoxonase activity polymorphism
  Nature Genetics, 1993
• A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
• Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins
  Clinical Genetics, 1991
• The world health organization monica project (monitoring trends and determinants in cardiovascular disease): A major international collaboration
  Journal of Clinical Epidemiology, 1988
• Linkage between the loci for cystic fibrosis and paraoxonase
  Clinical Genetics, 1986
• Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction.
  Clinical Chemistry, 1986